Both medications helped people lose weight and improve other weight-related conditions
For those receiving bimagrumab, there were significant decreases in fat mass ( 20.5%) compared to placebo ( 0.5%) and increase in lean mass (+ 3.6%) compared to placebo ( 0.8%)
Gruszka MD, PhD, an independent medical writer, who wrote the paper on behalf of Springer Healthcare Italia, and Monica Tambalo, PhD, who created the figures using BioRender.com on behalf of Springer Healthcare Italia
However, randomized controlled trials reported comparable dementia risk across treatments, likely due to limited follow-up duration and smaller cognitive outcome datasets 89
Association of B vitamin intake and total homocysteine levels with all-cause and cause-specific mortality in central obesity